Adaptive Biotechnologies Corp $ 39.82 -0.42 (-1.04%)
Volume:
655,407
Avg Vol (1m):
1,184,770
Market Cap $:
5.11 Bil
Enterprise Value $:
4.59 Bil
P/E (TTM):
0.00
P/B:
9.14
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 14.59 | ||
| Equity-to-Asset | 0.63 | ||
| Debt-to-Equity | 0.07 | ||
| Debt-to-EBITDA | -0.45 | ||
| Altman Z-Score | 9.33 | ||
Profitability Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -99.63 | ||
| Net Margin % | -87.47 | ||
| ROE % | -24.04 | ||
| ROA % | -10.41 | ||
| ROC (Joel Greenblatt) % | -225.22 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 9.14 | ||
| PS Ratio | 17.81 | ||
| EV-to-EBIT | -49.36 | ||
| EV-to-EBITDA | -54 | ||
| EV-to-Revenue | 49.18 | ||
| Current Ratio | 7.5 | ||
| Quick Ratio | 7.37 | ||
| Days Inventory | 142.31 | ||
| Days Sales Outstanding | 36.7 | ||
| Days Payable | 62.83 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History |
|---|
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 11.96 | ||
| Earnings Yield (Greenblatt) % | -2.03 |